The risk or severity of adverse effects can be increased when trifluoperazine is combined with Articaine.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with butamben.


The risk or severity of adverse effects can be increased when Olopatadine is combined with haloperidol.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Perospirone.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with tiagabine.


The risk or severity of adverse effects can be increased when captopril is combined with ibuprofen.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with zonisamide.


The risk or severity of adverse effects can be increased when amoxapine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with metoprolol.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when nadolol is combined with Nebivolol.


The risk or severity of adverse effects can be increased when medrysone is combined with metoclopramide.


The risk or severity of adverse effects can be increased when thiothixene is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when thiothixene is combined with Ramelteon.


The risk or severity of adverse effects can be increased when valsartan is combined with Clevidipine.


The risk or severity of adverse effects can be increased when D-mannitol is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Aliskiren.


The risk or severity of adverse effects can be increased when Pirlindole is combined with oxycodone.


The risk or severity of adverse effects can be increased when Pirlindole is combined with buspirone.


The risk or severity of adverse effects can be increased when reserpine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with dibucaine.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when chlormezanone is combined with paroxetine.


The risk or severity of adverse effects can be increased when diflunisal is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when isradipine is combined with cilazapril.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with citalopram.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Repaglinide.


The risk or severity of adverse effects can be increased when reserpine is combined with bupivacaine.


The risk or severity of adverse effects can be increased when reserpine is combined with Etomidate.


The risk or severity of adverse effects can be increased when Pipamperone is combined with doxazosin.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with levodopa.


The risk or severity of adverse effects can be increased when lithium ion is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when butorphanol is combined with midazolam.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with nifedipine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with nitrendipine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with chlormezanone.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Escitalopram.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when levallorphan is combined with Methylnaltrexone.


The risk or severity of adverse effects can be increased when quinapril is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Milnacipran.


The risk or severity of adverse effects can be increased when meclizine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when LISURIDE is combined with oxymetholone.


The risk or severity of adverse effects can be increased when olanzapine is combined with clidinium.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with proparacaine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Asenapine.


The risk or severity of adverse effects can be increased when fexofenadine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Apremilast is combined with flunisolide.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Halazepam.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when Perospirone is combined with Etidocaine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with fenbufen.


The risk or severity of adverse effects can be increased when perphenazine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when cilnidipine is combined with bumetanide.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with estrone.


The risk or severity of adverse effects can be increased when cilnidipine is combined with quinapril.


The risk or severity of adverse effects can be increased when cilnidipine is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when cilnidipine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when amisulpride is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when midazolam is combined with chlormezanone.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with Eprosartan.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when alprazolam is combined with tizanidine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with quinapril.


The risk or severity of adverse effects can be increased when niflumic acid is combined with estrone.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with bumetanide.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with cocaine.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with papaverine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when cabergoline is combined with sertraline.


The risk or severity of adverse effects can be increased when protriptyline is combined with loratadine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when diazepam is combined with olanzapine.


The risk or severity of adverse effects can be increased when l-ascorbic acid is combined with deferoxamine.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Bambuterol.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with flunarizine.


The risk or severity of adverse effects can be increased when morphine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Tapentadol is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when nimodipine is combined with enalapril.


The risk or severity of adverse effects can be increased when buspirone is combined with zonisamide.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Pizotifen.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with TRIPTORELIN.


The risk or severity of adverse effects can be increased when perphenazine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when minoxidil is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when docetaxel is combined with Regorafenib.


The risk or severity of adverse effects can be increased when Tramadol is combined with butorphanol.


The risk or severity of adverse effects can be increased when buspirone is combined with tiagabine.


The risk or severity of adverse effects can be increased when levodopa is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when alprazolam is combined with cetirizine.


The risk or severity of adverse effects can be increased when alprazolam is combined with protriptyline.


The risk or severity of adverse effects can be increased when glimepiride is combined with ethanol.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with polythiazide.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with droperidol.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when nortriptyline is combined with formoterol.


The risk or severity of adverse effects can be increased when Rotigotine is combined with valsartan.


The risk or severity of adverse effects can be increased when nitric oxide is combined with Torasemide.


The risk or severity of adverse effects can be increased when pentobarbital is combined with MELPERONE.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when amphotericin b is combined with tolazoline.


The risk or severity of adverse effects can be increased when Nepafenac is combined with acemetacin.


The risk or severity of adverse effects can be increased when lorazepam is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Rotigotine is combined with ramipril.


The risk or severity of adverse effects can be increased when nicergoline is combined with Dasatinib.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with anagrelide.


The risk or severity of adverse effects can be increased when levorphanol is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when carprofen is combined with formestane.


The risk or severity of adverse effects can be increased when nicergoline is combined with Lapatinib.


The risk or severity of adverse effects can be increased when pentobarbital is combined with zotepine.


The risk or severity of adverse effects can be increased when carprofen is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when Clevidipine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when enflurane is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when Spirapril is combined with nabumetone.


The risk or severity of adverse effects can be increased when Spirapril is combined with ketorolac.


The risk or severity of adverse effects can be increased when Spirapril is combined with tenoxicam.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with estrone.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Olopatadine.


The risk or severity of adverse effects can be increased when quetiapine is combined with Nebivolol.


The risk or severity of adverse effects can be increased when ethopropazine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Crizotinib is combined with oxycodone.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with diflorasone.


The risk or severity of adverse effects can be increased when morphine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when UMECLIDINIUM is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when morphine is combined with minoxidil.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when Pipotiazine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when prazepam is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Torasemide.


The risk or severity of adverse effects can be increased when Tolcapone is combined with citalopram.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with ouabain.


The risk or severity of adverse effects can be increased when alprazolam is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when alprazolam is combined with flunarizine.


The risk or severity of adverse effects can be increased when clozapine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when rasagiline is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when buspirone is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when indomethacin is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when Icatibant is combined with formestane.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when amphotericin b is combined with oxprenolol.


The risk or severity of adverse effects can be increased when clotrimazole is combined with Pregabalin.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when diflunisal is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when Lofexidine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when lorazepam is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Normethadone.


The risk or severity of adverse effects can be increased when tolmetin is combined with Tixocortol.


The risk or severity of adverse effects can be increased when benzoic acid is combined with Clevidipine.


The risk or severity of adverse effects can be increased when lisinopril is combined with epirizole.


The risk or severity of adverse effects can be increased when HEROIN is combined with desipramine.


The risk or severity of adverse effects can be increased when thiopental is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when quinapril is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when clozapine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when METYROSINE is combined with metoclopramide.


The risk or severity of adverse effects can be increased when gabapentin is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when baclofen is combined with METAXALONE.


The risk or severity of adverse effects can be increased when cetirizine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when protriptyline is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when protriptyline is combined with rasagiline.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when haloperidol is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when nicardipine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when amphotericin b is combined with papaverine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with nifedipine.


The risk or severity of adverse effects can be increased when DESONIDE is combined with Echothiophate.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when amifostine is combined with Carbetocin.


The risk or severity of adverse effects can be increased when Isoconazole is combined with xylometazoline.


The risk or severity of adverse effects can be increased when DESONIDE is combined with norfloxacin.


The risk or severity of adverse effects can be increased when prazepam is combined with Tolcapone.


The risk or severity of adverse effects can be increased when oxycodone is combined with estazolam.


The risk or severity of adverse effects can be increased when memantine is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when olanzapine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with tiagabine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with selegiline.


The risk or severity of adverse effects can be increased when niflumic acid is combined with Clobetasone.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with zonisamide.


The risk or severity of adverse effects can be increased when promazine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when oxycodone is combined with dantrolene.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Lofexidine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with resveratrol.


The risk or severity of adverse effects can be increased when pimozide is combined with butalbital.


The risk or severity of adverse effects can be increased when Talniflumate is combined with tolmetin.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with leflunomide.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with tiagabine.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with zonisamide.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Olopatadine.


The risk or severity of adverse effects can be increased when salicylamide is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when lidocaine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Flupentixol is combined with dyclonine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with propoxyphene.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when tacrolimus is combined with IMIQUIMOD.


The risk or severity of adverse effects can be increased when epoprostenol is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when Etomidate is combined with cetirizine.


The risk or severity of adverse effects can be increased when niflumic acid is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when hydromorphone is combined with METAXALONE.


The risk or severity of adverse effects can be increased when nortriptyline is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when benzocaine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when thiopental is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when propofol is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when propoxyphene is combined with meclizine.


The risk or severity of adverse effects can be increased when propofol is combined with oxazepam.


The risk or severity of adverse effects can be increased when isoflurane is combined with mesoridazine.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with Aliskiren.


The risk or severity of adverse effects can be increased when celecoxib is combined with niflumic acid.


The risk or severity of adverse effects can be increased when enalapril is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when docetaxel is combined with Vandetanib.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with Vecuronium.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with PIPECURONIUM.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with pancuronium.


The risk or severity of adverse effects can be increased when budesonide is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when cilnidipine is combined with pramipexole.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with medrysone.


The risk or severity of adverse effects can be increased when lorazepam is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when rasagiline is combined with mianserin.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with physostigmine.


The risk or severity of adverse effects can be increased when midazolam is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Nepafenac is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when cabergoline is combined with midazolam.


The risk or severity of adverse effects can be increased when rasagiline is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when amoxapine is combined with trimipramine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with thiamylal.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with brotizolam.


The risk or severity of adverse effects can be increased when flurazepam is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when HEROIN is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when mesoridazine is combined with halothane.


The risk or severity of adverse effects can be increased when flurazepam is combined with flunarizine.


The risk or severity of adverse effects can be increased when docetaxel is combined with albendazole.


The risk or severity of adverse effects can be increased when midazolam is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Olsalazine is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when HEROIN is combined with Tolvaptan.


The risk or severity of adverse effects can be increased when codeine is combined with Tolvaptan.


The risk or severity of adverse effects can be increased when codeine is combined with Asenapine.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when trazodone is combined with dantrolene.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with topiramate.


The risk or severity of adverse effects can be increased when ketamine is combined with thiothixene.


The risk or severity of adverse effects can be increased when QUINESTROL is combined with Ospemifene.


The risk or severity of adverse effects can be increased when ketamine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with D-mannitol.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with prednisone.


The risk or severity of adverse effects can be increased when ketamine is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when tolazoline is combined with furosemide.


The risk or severity of adverse effects can be increased when bromazepam is combined with Lurasidone.


The risk or severity of adverse effects can be increased when imipramine is combined with Sodium phosphate monobasic.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with nifedipine.


The risk or severity of adverse effects can be increased when triamterene is combined with dipyridamole.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with diazoxide.


The risk or severity of adverse effects can be increased when isoflurane is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when Imatinib is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when procarbazine is combined with Ziprasidone.


The risk or severity of adverse effects can be increased when epinephrine is combined with phenmetrazine.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with topiramate.


The risk or severity of adverse effects can be increased when itraconazole is combined with Efonidipine.


The risk or severity of adverse effects can be increased when itraconazole is combined with Lacidipine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with perphenazine.


The risk or severity of adverse effects can be increased when itraconazole is combined with Benidipine.


The risk or severity of adverse effects can be increased when itraconazole is combined with cilnidipine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when itraconazole is combined with manidipine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when Eletriptan is combined with linezolid.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Canrenoic acid.


The risk or severity of adverse effects can be increased when chloroquine is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when hydromorphone is combined with brotizolam.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with Riociguat.


The risk or severity of adverse effects can be increased when chloroquine is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with etodolac.


The risk or severity of adverse effects can be increased when procarbazine is combined with Lurasidone.


The risk or severity of adverse effects can be increased when metaproterenol is combined with METHAMPHETAMINE.


The risk or severity of adverse effects can be increased when vinblastine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with physostigmine.


The risk or severity of adverse effects can be increased when Linagliptin is combined with ramipril.


The risk or severity of adverse effects can be increased when fenoldopam is combined with ropinirole.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with baclofen.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when flumethasone is combined with memantine.


The risk or severity of adverse effects can be increased when haloperidol is combined with zaleplon.


The risk or severity of adverse effects can be increased when haloperidol is combined with mepivacaine.


The risk or severity of adverse effects can be increased when Micafungin is combined with flunarizine.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when methylergonovine is combined with oxymetholone.


The risk or severity of adverse effects can be increased when Pramocaine is combined with tizanidine.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when fosinopril is combined with antipyrine.


The risk or severity of adverse effects can be increased when flunisolide is combined with physostigmine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when bromocriptine is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when trimipramine is combined with ritodrine.


The risk or severity of adverse effects can be increased when flunisolide is combined with rivastigmine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with doxorubicin.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Icatibant.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when bromazepam is combined with Difenoxin.


The risk or severity of adverse effects can be increased when lorazepam is combined with Articaine.


The risk or severity of adverse effects can be increased when flunisolide is combined with norfloxacin.


The risk or severity of adverse effects can be increased when flunisolide is combined with Echothiophate.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with quazepam.


The risk or severity of adverse effects can be increased when cabergoline is combined with lidocaine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Iloperidone.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with loratadine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with imipramine.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with metolazone.


The risk or severity of adverse effects can be increased when Lofexidine is combined with terazosin.


The risk or severity of adverse effects can be increased when apomorphine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Normethadone is combined with ethotoin.


The risk or severity of adverse effects can be increased when celecoxib is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when methysergide is combined with clotrimazole.


The risk or severity of adverse effects can be increased when methysergide is combined with diethylstilbestrol.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with lithium ion.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when methylphenidate is combined with pramipexole.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with clonidine.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with difluprednate.


The risk or severity of adverse effects can be increased when sevoflurane is combined with imipramine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with prazosin.


The risk or severity of adverse effects can be increased when sevoflurane is combined with loratadine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with primidone.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Fospropofol.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when Conivaptan is combined with minoxidil.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with baclofen.


The risk or severity of adverse effects can be increased when dyclonine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Sacubitril.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when methoxamine is combined with dopamine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with losartan.


The risk or severity of adverse effects can be increased when butabarbital is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when chloroquine is combined with dapsone.


The risk or severity of adverse effects can be increased when methysergide is combined with ifosfamide.


The risk or severity of adverse effects can be increased when chloroquine is combined with medrysone.


The risk or severity of adverse effects can be increased when carisoprodol is combined with venlafaxine.


The risk or severity of adverse effects can be increased when morphine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when butorphanol is combined with procarbazine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with atorvastatin.


The risk or severity of adverse effects can be increased when risperidone is combined with MELPERONE.


The risk or severity of adverse effects can be increased when oxycodone is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when sulpiride is combined with methylphenidate.


The risk or severity of adverse effects can be increased when sulpiride is combined with methocarbamol.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when HEROIN is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Lacidipine is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when HEROIN is combined with flunarizine.


The risk or severity of adverse effects can be increased when HEROIN is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with prednisone.


The risk or severity of adverse effects can be increased when sevoflurane is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when morphine is combined with Efonidipine.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with butalbital.


The risk or severity of adverse effects can be increased when glutethimide is combined with tetracaine.


The risk or severity of adverse effects can be increased when rapamycin is combined with Efonidipine.


The risk or severity of adverse effects can be increased when chloroquine is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when isoflurane is combined with furosemide.


The risk or severity of adverse effects can be increased when propoxyphene is combined with dantrolene.


The risk or severity of adverse effects can be increased when isoflurane is combined with tizanidine.


The risk or severity of adverse effects can be increased when isoflurane is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when isoflurane is combined with phentolamine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with tiapride.


The risk or severity of adverse effects can be increased when propantheline is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when nimodipine is combined with Eprosartan.


The risk or severity of adverse effects can be increased when tizanidine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with haloperidol.


The risk or severity of adverse effects can be increased when sulpiride is combined with digoxin.


The risk or severity of adverse effects can be increased when butabarbital is combined with butorphanol.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Pizotifen.


The risk or severity of adverse effects can be increased when sulpiride is combined with carisoprodol.


The risk or severity of adverse effects can be increased when proparacaine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with cetirizine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when proparacaine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when proparacaine is combined with amoxapine.


The risk or severity of adverse effects can be increased when Icatibant is combined with loteprednol.


The risk or severity of adverse effects can be increased when bupivacaine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with physostigmine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with clidinium.


The risk or severity of adverse effects can be increased when bupivacaine is combined with papaverine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with rivastigmine.


The risk or severity of adverse effects can be increased when ATROPINE is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when Nepafenac is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when sulindac is combined with suprofen.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with tizanidine.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Butethal is combined with sertraline.


The risk or severity of adverse effects can be increased when valsartan is combined with acebutolol.


The risk or severity of adverse effects can be increased when ketamine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when valsartan is combined with captopril.


The risk or severity of adverse effects can be increased when trandolapril is combined with Pregabalin.


The risk or severity of adverse effects can be increased when Fesoterodine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when procaine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with levorphanol.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with Riociguat.


The risk or severity of adverse effects can be increased when triflupromazine is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when carvedilol is combined with Cevimeline.


The risk or severity of adverse effects can be increased when clonazepam is combined with Retigabine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Etidocaine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when triazolam is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when floctafenine is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when nicardipine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when tenoxicam is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when sertraline is combined with bromocriptine.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when mecamylamine is combined with oxycodone.


The risk or severity of adverse effects can be increased when bumetanide is combined with ribostamycin.


The risk or severity of adverse effects can be increased when Olopatadine is combined with equilin.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when pergolide is combined with clozapine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with papaverine.


The risk or severity of adverse effects can be increased when pergolide is combined with vinorelbine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with nifedipine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with halothane.


The risk or severity of adverse effects can be increased when midazolam is combined with methocarbamol.


The risk or severity of adverse effects can be increased when midazolam is combined with triprolidine.


The risk or severity of adverse effects can be increased when thioridazine is combined with bumetanide.


The risk or severity of adverse effects can be increased when thioridazine is combined with quinapril.


The risk or severity of adverse effects can be increased when thioridazine is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when thioridazine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when procaine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with Aliskiren.


The risk or severity of adverse effects can be increased when amisulpride is combined with ethotoin.


The risk or severity of adverse effects can be increased when celecoxib is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when Torasemide is combined with Eprosartan.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Remoxipride.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with floctafenine.


The risk or severity of adverse effects can be increased when perphenazine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Toloxatone is combined with Salmeterol.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with METAXALONE.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Clobetasone.


The risk or severity of adverse effects can be increased when ramipril is combined with flurbiprofen.


The risk or severity of adverse effects can be increased when halothane is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Toloxatone is combined with maprotiline.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when methazolamide is combined with Riociguat.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when methscopolamine is combined with oxycodone.


The risk or severity of adverse effects can be increased when midazolam is combined with carisoprodol.


The risk or severity of adverse effects can be increased when clozapine is combined with Sacubitril.


The risk or severity of adverse effects can be increased when hydromorphone is combined with triflupromazine.


The risk or severity of adverse effects can be increased when triazolam is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when fluocinonide is combined with mefloquine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Retigabine.


The risk or severity of adverse effects can be increased when amitriptyline is combined with fexofenadine.


The risk or severity of adverse effects can be increased when amitriptyline is combined with rizatriptan.


The risk or severity of adverse effects can be increased when amitriptyline is combined with naratriptan.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with trimipramine.


The risk or severity of adverse effects can be increased when quetiapine is combined with lidocaine.


The risk or severity of adverse effects can be increased when sotalol is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with procaine.


The risk or severity of adverse effects can be increased when isoflurane is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Salsalate.


The risk or severity of adverse effects can be increased when desipramine is combined with periciazine.


The risk or severity of adverse effects can be increased when triazolam is combined with gabapentin.


The risk or severity of adverse effects can be increased when cilazapril is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with triprolidine.


The risk or severity of adverse effects can be increased when maprotiline is combined with doxepin.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with spironolactone.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with methocarbamol.


The risk or severity of adverse effects can be increased when maprotiline is combined with nefazodone.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with METAXALONE.


The risk or severity of adverse effects can be increased when bromazepam is combined with METAXALONE.


The risk or severity of adverse effects can be increased when losartan is combined with quetiapine.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with PIPECURONIUM.


The risk or severity of adverse effects can be increased when metolazone is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with estrone.


The risk or severity of adverse effects can be increased when meprobamate is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with Vecuronium.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when mesoridazine is combined with trimipramine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Metipranolol.


The risk or severity of adverse effects can be increased when rescinnamine is combined with epirizole.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when dyclonine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when dyclonine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with triazolam.


The risk or severity of adverse effects can be increased when bepridil is combined with reserpine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with HEROIN.


The risk or severity of adverse effects can be increased when butamben is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with etizolam.


The risk or severity of adverse effects can be increased when floctafenine is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when butamben is combined with flunarizine.


The risk or severity of adverse effects can be increased when halothane is combined with Olopatadine.


The risk or severity of adverse effects can be increased when amoxapine is combined with formoterol.


The risk or severity of adverse effects can be increased when flurazepam is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when alclofenac is combined with medrysone.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with zaleplon.


The risk or severity of adverse effects can be increased when Phenelzine is combined with ropinirole.


The risk or severity of adverse effects can be increased when bromazepam is combined with thiopental.


The risk or severity of adverse effects can be increased when formestane is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when bromazepam is combined with ethosuximide.


The risk or severity of adverse effects can be increased when procaine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with primidone.


The risk or severity of adverse effects can be increased when leflunomide is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when amiodarone is combined with arsenic trioxide.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Clobetasone.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when MELPERONE is combined with flunarizine.


The risk or severity of adverse effects can be increased when Alvimopan is combined with Naloxegol.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with brotizolam.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with pancuronium.


The risk or severity of adverse effects can be increased when oxazepam is combined with maprotiline.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with medrysone.


The risk or severity of adverse effects can be increased when MELPERONE is combined with nortriptyline.


The risk or severity of adverse effects can be increased when MELPERONE is combined with amoxapine.


The risk or severity of adverse effects can be increased when midazolam is combined with Milnacipran.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with PIPECURONIUM.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with Vecuronium.


The risk or severity of adverse effects can be increased when acemetacin is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with Torasemide.


The risk or severity of adverse effects can be increased when thiothixene is combined with oxprenolol.


The risk or severity of adverse effects can be increased when halothane is combined with fosinopril.


The risk or severity of adverse effects can be increased when prednisone is combined with fleroxacin.


The risk or severity of adverse effects can be increased when amifostine is combined with pramipexole.


The risk or severity of adverse effects can be increased when clozapine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Desloratadine is combined with PIPECURONIUM.


The risk or severity of adverse effects can be increased when Desloratadine is combined with Vecuronium.


The risk or severity of adverse effects can be increased when efavirenz is combined with ritonavir.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with dexamethasone.


The risk or severity of adverse effects can be increased when Cangrelor is combined with Olsalazine.


The risk or severity of adverse effects can be increased when Almotriptan is combined with desipramine.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with alclometasone.


The risk or severity of adverse effects can be increased when Tolcapone is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with paroxetine.


The risk or severity of adverse effects can be increased when dyclonine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when dyclonine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Tapentadol is combined with furosemide.


The risk or severity of adverse effects can be increased when propofol is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when dyclonine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when propofol is combined with glutethimide.


The risk or severity of adverse effects can be increased when methscopolamine is combined with HEROIN.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with oxymorphone.


The risk or severity of adverse effects can be increased when hexetidine is combined with flunarizine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with methadone.


The risk or severity of adverse effects can be increased when meperidine is combined with flurazepam.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with doxepin.


The risk or severity of adverse effects can be increased when Risedronic acid is combined with pravastatin.


The risk or severity of adverse effects can be increased when meperidine is combined with tizanidine.


The risk or severity of adverse effects can be increased when Sitagliptin is combined with captopril.


The risk or severity of adverse effects can be increased when diclofenac is combined with diflorasone.


The risk or severity of adverse effects can be increased when benzocaine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when periciazine is combined with methylphenidate.


The risk or severity of adverse effects can be increased when etodolac is combined with amcinonide.


The risk or severity of adverse effects can be increased when Phenelzine is combined with bumetanide.


The risk or severity of adverse effects can be increased when codeine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when etodolac is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when dibucaine is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when Phenelzine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when meperidine is combined with potassium ion.


The risk or severity of adverse effects can be increased when perphenazine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with phenytoin.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with Clobetasone.


The risk or severity of adverse effects can be increased when Butoconazole is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Tramadol is combined with tetracaine.


The risk or severity of adverse effects can be increased when codeine is combined with mesoridazine.


The risk or severity of adverse effects can be increased when amiodarone is combined with minoxidil.


The risk or severity of adverse effects can be increased when moclobemide is combined with reserpine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with lisinopril.


The risk or severity of adverse effects can be increased when meperidine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Etidocaine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Sorafenib is combined with carboplatin.


The risk or severity of adverse effects can be increased when buspirone is combined with Pramocaine.


The risk or severity of adverse effects can be increased when gabapentin is combined with topiramate.


The risk or severity of adverse effects can be increased when enflurane is combined with tizanidine.


The risk or severity of adverse effects can be increased when buspirone is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when oxybutynin is combined with levorphanol.


The risk or severity of adverse effects can be increased when antipyrine is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when buprenorphine is combined with indapamide.


The risk or severity of adverse effects can be increased when amobarbital is combined with butamben.


The risk or severity of adverse effects can be increased when antipyrine is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when Tramadol is combined with ethotoin.


The risk or severity of adverse effects can be increased when codeine is combined with maprotiline.


The risk or severity of adverse effects can be increased when Tramadol is combined with isoflurane.


The risk or severity of adverse effects can be increased when Tramadol is combined with prilocaine.


The risk or severity of adverse effects can be increased when argatroban is combined with Apixaban.


The risk or severity of adverse effects can be increased when polythiazide is combined with diazoxide.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when rescinnamine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with difluprednate.


The risk or severity of adverse effects can be increased when butabarbital is combined with primidone.


The risk or severity of adverse effects can be increased when Nebivolol is combined with Aliskiren.


The risk or severity of adverse effects can be increased when Almotriptan is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when butorphanol is combined with butamben.


The risk or severity of adverse effects can be increased when paroxetine is combined with imipramine.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with desoximetasone.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when isradipine is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when ethopropazine is combined with cyclopentolate.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with mepivacaine.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with metoclopramide.


The risk or severity of adverse effects can be increased when loratadine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when methysergide is combined with Luliconazole.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with amitriptyline.


The risk or severity of adverse effects can be increased when methylene blue is combined with lithium ion.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with scopolamine.


The risk or severity of adverse effects can be increased when Articaine is combined with tiapride.


The risk or severity of adverse effects can be increased when Desloratadine is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when melphalan is combined with leflunomide.


The risk or severity of adverse effects can be increased when pyridostigmine is combined with nicotine.


The risk or severity of adverse effects can be increased when pyridostigmine is combined with Cevimeline.


The risk or severity of adverse effects can be increased when amobarbital is combined with paroxetine.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with levorphanol.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with ibuprofen.


The risk or severity of adverse effects can be increased when tubocurarine is combined with hydromorphone.


The risk or severity of adverse effects can be increased when pentazocine is combined with baclofen.


The risk or severity of adverse effects can be increased when clorazepate is combined with efavirenz.


The risk or severity of adverse effects can be increased when meperidine is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when citalopram is combined with Pipamperone.


The risk or severity of adverse effects can be increased when pentazocine is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when ritodrine is combined with METHAMPHETAMINE.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when bumetanide is combined with Epirubicin.


The risk or severity of adverse effects can be increased when butabarbital is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Flupentixol.


The risk or severity of adverse effects can be increased when butabarbital is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when atorvastatin is combined with rescinnamine.


The risk or severity of adverse effects can be increased when ritonavir is combined with meperidine.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when temazepam is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when temazepam is combined with Escitalopram.


The risk or severity of adverse effects can be increased when lorazepam is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Masoprocol is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when nitrazepam is combined with clonazepam.


The risk or severity of adverse effects can be increased when nitrazepam is combined with promethazine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with phenytoin.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Melatonin.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when mesoridazine is combined with butamben.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with methscopolamine.


The risk or severity of adverse effects can be increased when levodopa is combined with Milnacipran.


The risk or severity of adverse effects can be increased when ethopropazine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when Tramadol is combined with benzocaine.


The risk or severity of adverse effects can be increased when Tramadol is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when Tramadol is combined with vigabatrin.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Enasidenib.


The risk or severity of adverse effects can be increased when clozapine is combined with nifedipine.


The risk or severity of adverse effects can be increased when risperidone is combined with Fospropofol.


The risk or severity of adverse effects can be increased when clozapine is combined with papaverine.


The risk or severity of adverse effects can be increased when indomethacin is combined with tenoxicam.


The risk or severity of adverse effects can be increased when baclofen is combined with Retigabine.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with lithium ion.


The risk or severity of adverse effects can be increased when baclofen is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when quazepam is combined with paroxetine.


The risk or severity of adverse effects can be increased when Remikiren is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when tolmetin is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when morphine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when morphine is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when morphine is combined with bumetanide.


The risk or severity of adverse effects can be increased when butamben is combined with fexofenadine.


The risk or severity of adverse effects can be increased when etodolac is combined with Olopatadine.


The risk or severity of adverse effects can be increased when sulpiride is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when propantheline is combined with tolterodine.


The risk or severity of adverse effects can be increased when Remoxipride is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when procarbazine is combined with moclobemide.


The risk or severity of adverse effects can be increased when epoprostenol is combined with Clevidipine.


The risk or severity of adverse effects can be increased when alprazolam is combined with propofol.


The risk or severity of adverse effects can be increased when nefazodone is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with baclofen.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with trazodone.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Olopatadine.


The risk or severity of adverse effects can be increased when ibuprofen is combined with Propacetamol.


The risk or severity of adverse effects can be increased when pergolide is combined with clotiazepam.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Lurasidone.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with fexofenadine.


The risk or severity of adverse effects can be increased when nystatin is combined with bepridil.


The risk or severity of adverse effects can be increased when zopiclone is combined with lidocaine.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with salicylamide.


The risk or severity of adverse effects can be increased when midazolam is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when pergolide is combined with cisapride.


The risk or severity of adverse effects can be increased when enalapril is combined with ibuprofen.


The risk or severity of adverse effects can be increased when midazolam is combined with Ramelteon.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Arotinolol.


The risk or severity of adverse effects can be increased when Tramadol is combined with triprolidine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when Telmisartan is combined with etodolac.


The risk or severity of adverse effects can be increased when lithium ion is combined with Difenoxin.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Butethal.


The risk or severity of adverse effects can be increased when Tolcapone is combined with cilazapril.


The risk or severity of adverse effects can be increased when Tramadol is combined with spironolactone.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with minoxidil.


The risk or severity of adverse effects can be increased when paroxetine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when lithium ion is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when toremifene is combined with Ospemifene.


The risk or severity of adverse effects can be increased when Milnacipran is combined with periciazine.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when chlormezanone is combined with imipramine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when amitriptyline is combined with nortriptyline.


The risk or severity of adverse effects can be increased when nimesulide is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when nisoldipine is combined with acebutolol.


The risk or severity of adverse effects can be increased when cilazapril is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Torasemide.


The risk or severity of adverse effects can be increased when linezolid is combined with Lurasidone.


The risk or severity of adverse effects can be increased when chlormezanone is combined with loratadine.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with nimesulide.


The risk or severity of adverse effects can be increased when selegiline is combined with acebutolol.


The risk or severity of adverse effects can be increased when Tramadol is combined with midazolam.


The risk or severity of adverse effects can be increased when bumetanide is combined with paromomycin.


The risk or severity of adverse effects can be increased when Ezetimibe is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Remoxipride is combined with mepivacaine.


The risk or severity of adverse effects can be increased when pergolide is combined with histamine.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Perampanel is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with clenbuterol.


The risk or severity of adverse effects can be increased when zopiclone is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Retigabine.


The risk or severity of adverse effects can be increased when quazepam is combined with Fospropofol.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with Bambuterol.


The risk or severity of adverse effects can be increased when thiopental is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Etidocaine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when thioridazine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when reserpine is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when reserpine is combined with pentobarbital.


The risk or severity of adverse effects can be increased when reserpine is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with halothane.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Bretylium.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with thiothixene.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with carisoprodol.


The risk or severity of adverse effects can be increased when reserpine is combined with codeine.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when benzocaine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when trazodone is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when tetrahydrozoline is combined with hydroxyamphetamine.


The risk or severity of adverse effects can be increased when Cobicistat is combined with oxycodone.


The risk or severity of adverse effects can be increased when quinapril is combined with indomethacin.


The risk or severity of adverse effects can be increased when zopiclone is combined with amisulpride.


The risk or severity of adverse effects can be increased when nitrendipine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when quinapril is combined with Masoprocol.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with fexofenadine.


The risk or severity of adverse effects can be increased when secobarbital is combined with butamben.


The risk or severity of adverse effects can be increased when phenylephrine is combined with oxymetazoline.


The risk or severity of adverse effects can be increased when Tolcapone is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Apremilast is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when Apremilast is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Pirlindole is combined with ritodrine.


The risk or severity of adverse effects can be increased when rapamycin is combined with Pinaverium.


The risk or severity of adverse effects can be increased when buprenorphine is combined with QUINETHAZONE.


The risk or severity of adverse effects can be increased when buprenorphine is combined with polythiazide.


The risk or severity of adverse effects can be increased when diazepam is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when rescinnamine is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when diazepam is combined with Ramelteon.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Venetoclax.


The risk or severity of adverse effects can be increased when tolmetin is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when moclobemide is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Remoxipride is combined with cetirizine.


The risk or severity of adverse effects can be increased when Melatonin is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when Remoxipride is combined with protriptyline.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with PIRBUTEROL.


The risk or severity of adverse effects can be increased when Spirapril is combined with Nepafenac.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with tubocurarine.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Salsalate.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when sulfisoxazole is combined with methotrexate.


The risk or severity of adverse effects can be increased when thiopental is combined with clonidine.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Retigabine.


The risk or severity of adverse effects can be increased when captopril is combined with Salsalate.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Tixocortol.


The risk or severity of adverse effects can be increased when Arotinolol is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Eletriptan is combined with triflupromazine.


The risk or severity of adverse effects can be increased when mafenide is combined with prilocaine.


The risk or severity of adverse effects can be increased when apomorphine is combined with cilnidipine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with scopolamine.


The risk or severity of adverse effects can be increased when methysergide is combined with cyclosporin A.


The risk or severity of adverse effects can be increased when apomorphine is combined with Lacidipine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with D-mannitol.


The risk or severity of adverse effects can be increased when loteprednol is combined with tubocurarine.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with cinoxacin.


The risk or severity of adverse effects can be increased when bromocriptine is combined with azithromycin.


The risk or severity of adverse effects can be increased when methylergonovine is combined with pergolide.


The risk or severity of adverse effects can be increased when bromocriptine is combined with caffeine.


The risk or severity of adverse effects can be increased when duloxetine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when buspirone is combined with halothane.


The risk or severity of adverse effects can be increased when nitrazepam is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when busulfan is combined with clozapine.


The risk or severity of adverse effects can be increased when chlormezanone is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when buspirone is combined with desipramine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when buspirone is combined with thiamylal.


The risk or severity of adverse effects can be increased when reserpine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when ritodrine is combined with tetrahydrozoline.


The risk or severity of adverse effects can be increased when niflumic acid is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when duloxetine is combined with moclobemide.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Salsalate.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when Apremilast is combined with flumethasone.


The risk or severity of adverse effects can be increased when pimozide is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Phenelzine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Treprostinil is combined with diflunisal.


The risk or severity of adverse effects can be increased when pentobarbital is combined with dibucaine.


The risk or severity of adverse effects can be increased when methysergide is combined with nitrendipine.


The risk or severity of adverse effects can be increased when docetaxel is combined with EXEMESTANE.


The risk or severity of adverse effects can be increased when docetaxel is combined with Methyl aminolevulinate.


The risk or severity of adverse effects can be increased when docetaxel is combined with azathioprine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with betamethasone.


The risk or severity of adverse effects can be increased when docetaxel is combined with doxorubicin.


The risk or severity of adverse effects can be increased when haloperidol is combined with Paliperidone.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when ILOPROST is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when lorazepam is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when antipyrine is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when lorazepam is combined with phenobarbital.


The risk or severity of adverse effects can be increased when pimozide is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when phenytoin is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Treprostinil is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when nimodipine is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when alclometasone is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when thiopental is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when alclometasone is combined with tubocurarine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with ethosuximide.


The risk or severity of adverse effects can be increased when propoxyphene is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when prilocaine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when haloperidol is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when haloperidol is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Pipamperone is combined with carvedilol.


The risk or severity of adverse effects can be increased when zaleplon is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when Paliperidone is combined with butalbital.


The risk or severity of adverse effects can be increased when Naftifine is combined with barnidipine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when Pramocaine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Pramocaine is combined with flunarizine.


The risk or severity of adverse effects can be increased when promazine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when clotrimazole is combined with Amrinone.


The risk or severity of adverse effects can be increased when spironolactone is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Flupentixol is combined with flunarizine.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with selegiline.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with desipramine.


The risk or severity of adverse effects can be increased when Articaine is combined with tizanidine.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with Vorapaxar.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when LISURIDE is combined with metyrapone.


The risk or severity of adverse effects can be increased when LISURIDE is combined with glyburide.


The risk or severity of adverse effects can be increased when LISURIDE is combined with sulfamethoxazole.


The risk or severity of adverse effects can be increased when paramethasone is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when ondansetron is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when paramethasone is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when zaleplon is combined with oxymorphone.


The risk or severity of adverse effects can be increased when amifostine is combined with Bortezomib.


The risk or severity of adverse effects can be increased when minoxidil is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when SOMATOSTATIN is combined with primidone.


The risk or severity of adverse effects can be increased when isoflurane is combined with MOXONIDINE.


The risk or severity of adverse effects can be increased when propofol is combined with hydralazine.


The risk or severity of adverse effects can be increased when diazepam is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when diazepam is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when methylergonovine is combined with tetracycline.


The risk or severity of adverse effects can be increased when methylergonovine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when fosinopril is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with epirizole.


The risk or severity of adverse effects can be increased when minoxidil is combined with Aliskiren.


The risk or severity of adverse effects can be increased when Spirapril is combined with salicylamide.


The risk or severity of adverse effects can be increased when amifostine is combined with imipramine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Halobetasol is combined with metoclopramide.


The risk or severity of adverse effects can be increased when flurazepam is combined with butalbital.


The risk or severity of adverse effects can be increased when procaine is combined with clomipramine.


The risk or severity of adverse effects can be increased when butabarbital is combined with dibucaine.


The risk or severity of adverse effects can be increased when procyclidine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with alprostadil.


The risk or severity of adverse effects can be increased when Eletriptan is combined with olanzapine.


The risk or severity of adverse effects can be increased when ibuprofen is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with tirofiban.


The risk or severity of adverse effects can be increased when Eletriptan is combined with methadone.


The risk or severity of adverse effects can be increased when benztropine is combined with meperidine.


The risk or severity of adverse effects can be increased when Spirapril is combined with Pregabalin.


The risk or severity of adverse effects can be increased when olanzapine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when terconazole is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when HEROIN is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when oxymorphone is combined with zotepine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with MELPERONE.


The risk or severity of adverse effects can be increased when aspirin is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when Etomidate is combined with sertraline.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with Fesoterodine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Salmeterol.


The risk or severity of adverse effects can be increased when Metipranolol is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when fluocinonide is combined with decamethonium.


The risk or severity of adverse effects can be increased when scopolamine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with Levocetirizine.